Zurueck zur Suche

Reporte zur Charge UT7683KA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 GA 2 CO 1 AL 1

VAERS 2491388

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

schwer
Staat
GA
Alter
65,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Feeling abnormal Hypertension Nausea Pyrexia Syncope

Symptomtext

Day of VacinnationSyncopal episode, hypertension, dizzy, nausea, improved somewhat after 40 minutes, no other treatment provided other than recumbant position and cold compress. Day 1 feverish and light-headed, took ibuprofen Day 2 nausea off and on all day. Day 3 continue to be light-headed, periods of dizziness, and "foggy" which has continued off and on to present.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
hypothyroid
Andere Medikamente
Synthroid
Allergien
none
Vorherige Impfungen
-

VAERS 2572089

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge ut7683ka

moderat
Staat
-
Alter
41,0
Geschlecht
F
Eingang
31.01.2023
Impfdatum
07.10.2022
Beginn
20.10.2022
Tage bis Beginn
13,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Cardiac monitoring Cardiac stress test Decreased appetite Dizziness Nausea Palpitations Vision blurred Weight decreased

Symptomtext

dizzyness,heart palpitations,weight loss,blurry vission;loss appetite nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
blood test,heart monitor ,stress test ,
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493112

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

moderat
Staat
CO
Alter
36,0
Geschlecht
F
Eingang
28.10.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cough Erythema Immediate post-injection reaction Paraesthesia Paraesthesia oral

Symptomtext

Immediately has a fire engine red face, neck, chest and arms; tingling in tongue and fingertips; cough. Went to ED and received IV benedryl and steroids. Given a script for epi pen. Following IV's skin color returned to normal and discharged home without incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
None known
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2499260

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7683ka

mild
Staat
TX
Alter
62,0
Geschlecht
M
Eingang
04.11.2022
Impfdatum
08.10.2022
Beginn
08.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Impaired work ability Malaise Pain Pyrexia

Symptomtext

fever, pain, cough--patient says it's extreme and is still sick one month later, he has had to miss work, has seen the dr. and nothing helps. He insists that the Covid booster shot gave him Covid and says he's very sick and would like a return call to discuss.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
Patient has seen the dr. but I'm not sure what tests were performed.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2488575

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

mild
Staat
GA
Alter
41,0
Geschlecht
F
Eingang
25.10.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site haemorrhage Injection site swelling Product leakage

Symptomtext

When I received my COVID vaccine, there was some overspill of the vaccine and blood that spilled out of the injection site. The vaccinating RN told me to put some pressure on it. And to monitor the site for more bleeding. I received the vaccine around 09:00. Around 15:00, I took off my bandaid to check the site, and I noticed that I now have a bump at the injection site. It is not a large bump, about 1 cm in diameter. The bump is subcutaneous, I cannot see it from the surface, but I feel it.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site haemorrhage
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Prenatal vitamins 1 tab daily, evening primrose oil 1000 mg daily, zinc gluconate 50 mg daily, cetirizine 10 mg daily PRN for seasonal allergies, spironolactone 25 mg daily
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2466632

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

mild
Staat
TX
Alter
61,0
Geschlecht
F
Eingang
01.10.2022
Impfdatum
26.09.2022
Beginn
26.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Flank pain Pleuritic pain

Symptomtext

Flank or pleuritic pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Flank pain
Hospital-Tage
-
Labordaten
n/a. Office visit
Aktuelle Erkrankungen
None
Vorgeschichte
Mild, intermittent Asthma
Andere Medikamente
Albuterol inhaler
Allergien
Cipro, mercury
Vorherige Impfungen
-

VAERS 2701632

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

gering
Staat
AL
Alter
56,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
01.10.2023
Beginn
25.10.2023
Tage bis Beginn
24,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
none
Vorgeschichte
HTN, COPD
Andere Medikamente
metoprolol, succinate, fish oil500mg, multi vitamin, biotin, cranberry, Senokot
Allergien
codeine
Vorherige Impfungen
-

VAERS 2511396

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7683KA

gering
Staat
TX
Alter
0,3
Geschlecht
F
Eingang
18.11.2022
Impfdatum
10.11.2022
Beginn
10.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product use issue

Symptomtext

4-month old patient was accidentally given Fluzone Quadrivalent WIth no reported adverse event; Initial information received on 10-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves a 4 months old female patient who was accidentally given fluzone quadrivalent with no reported adverse event while receiving vaccine influenza quadrival A-B vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (MMR). On 10-Nov-2022, the patient received a dose of suspect influenza quadrival A-B vaccine Suspension for injection at a dose of 0.5 ml with lot UT7683KA and expiry date- 30-Jun-2023 via unknown route in unknown administration site for influenza. On 10-Nov-2022, 4-month old patient was accidentally given fluzone quadrivalent with no reported adverse event (product use issue) following the administration of influenza quadrival A-B vaccine (latency unknown). Action taken: not applicable It was not reported if the patient received a corrective treatment for the event Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-